HIV gp120 vaccine (VaxGen)

N/A

Report date: 2025/07/17 20:00:09

Base Information

Drug NameHIV gp120 vaccine (VaxGen)
Drug Alias NameAIDSVAX B/B'AIDSVAX B/EAIDSVAXB/BHIV gp120 vaccine AIDSVAXHIV gp120 vaccine +[7] 
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLupus Erythematosus, SystemicHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesThailand
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthEmergent Biosolutions IncGenentech Inc +[4] 
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A